Summary

The global Cardiotocography market size was US$ 392 million in 2025 and is forecast to reach a readjusted size of US$ 524 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Cardiotocography (CTG), also known as Electronic Fetal Monitoring (EFM), which can monitor both the fetal heart rate and uterine contractions. This method provides a paper recording of the fetal heart rate and the uterine contractions, but prevents the mother from leaving the hospital bed and restricts general movement.
The cardiotocography (CTG) market is being driven by the growing global emphasis on improving maternal and fetal health outcomes. CTG is a vital prenatal monitoring technology used to assess fetal heart rate and uterine contractions during pregnancy and labor, helping healthcare providers detect fetal distress and prevent complications such as hypoxia or stillbirth. The rising global birth rate, especially in developing countries, and increasing awareness of prenatal care are boosting the demand for CTG devices. In developed regions, the adoption of advanced and digital CTG systems is fueled by technological innovations, including wireless monitoring, real-time data integration with electronic medical records, and remote patient monitoring capabilities. These innovations enhance clinical decision-making and workflow efficiency, especially in high-risk pregnancies. Additionally, government initiatives and funding aimed at reducing maternal and infant mortality—such as those led by the WHO and national health programs—are supporting the expansion of prenatal monitoring infrastructure. Private and public investments in modernizing healthcare facilities and the growing number of maternity clinics and hospitals globally also contribute to the market’s positive trajectory.
Despite its benefits, the CTG market faces several challenges that could hinder broader adoption. One of the primary issues is the lack of trained healthcare professionals in many low- and middle-income countries, which limits the effective use and interpretation of CTG data. In these regions, outdated or insufficient monitoring infrastructure further hampers accurate prenatal assessment. Moreover, CTG interpretation can be subjective and prone to variability among clinicians, leading to false positives and unnecessary interventions such as cesarean sections, which raise healthcare costs and risks. There is also a growing debate in the medical community about the overuse of CTG in low-risk pregnancies, with some studies suggesting it does not significantly reduce neonatal morbidity or mortality in such cases. Additionally, the high cost of advanced CTG machines with integrated digital and telemetry functions may be prohibitive for smaller clinics and rural hospitals. Data privacy and integration concerns also arise when using cloud-based or wireless systems, especially in regions with limited digital infrastructure or unclear data protection laws. Addressing these challenges will require not only technological innovation but also investment in training, standardization of interpretation protocols, and equitable access to quality maternal healthcare.
The global Cardiotocography market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
GE Healthcare
Philips Healthcare
Edan Instruments
BIOLIGHT
ArjoHuntleigh
Contec Medical Systems
Sunray Medical Apparatus
Bionet
Luckcome
Medgyn Products
BRAEL-Medical Equipment
Medical ECONET
BabyFun
Yuwell
HealForce
Segment by Type
Traditional CTG
Intelligent CTG
Segment by Application
Hospital
Home
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Cardiotocography sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Cardiotocography manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Cardiotocography product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cardiotocography value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Cardiotocography Product Scope
1.2 Cardiotocography by Type
1.2.1 Global Cardiotocography Sales by Type (2021, 2025 & 2032)
1.2.2 Traditional CTG
1.2.3 Intelligent CTG
1.3 Cardiotocography by Application
1.3.1 Global Cardiotocography Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospital
1.3.3 Home
1.4 Global Cardiotocography Market Estimates and Forecasts (2021-2032)
1.4.1 Global Cardiotocography Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Cardiotocography Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Cardiotocography Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Cardiotocography Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Cardiotocography Historical Market Scenario by Region (2021-2026)
2.2.1 Global Cardiotocography Sales Market Share by Region (2021-2026)
2.2.2 Global Cardiotocography Revenue Market Share by Region (2021-2026)
2.3 Global Cardiotocography Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Cardiotocography Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Cardiotocography Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Cardiotocography Market Size and Prospects (2021-2032)
2.4.2 Europe Cardiotocography Market Size and Prospects (2021-2032)
2.4.3 China Cardiotocography Market Size and Prospects (2021-2032)
2.4.4 Japan Cardiotocography Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Cardiotocography Historical Market Review by Type (2021-2026)
3.1.1 Global Cardiotocography Sales by Type (2021-2026)
3.1.2 Global Cardiotocography Revenue by Type (2021-2026)
3.1.3 Global Cardiotocography Average Price by Type (2021-2026)
3.2 Global Cardiotocography Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Cardiotocography Sales Forecast by Type (2027-2032)
3.2.2 Global Cardiotocography Revenue Forecast by Type (2027-2032)
3.2.3 Global Cardiotocography Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Cardiotocography
4 Global Market Size by Application
4.1 Global Cardiotocography Historical Market Review by Application (2021-2026)
4.1.1 Global Cardiotocography Sales by Application (2021-2026)
4.1.2 Global Cardiotocography Revenue by Application (2021-2026)
4.1.3 Global Cardiotocography Average Price by Application (2021-2026)
4.2 Global Cardiotocography Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Cardiotocography Sales Forecast by Application (2027-2032)
4.2.2 Global Cardiotocography Revenue Forecast by Application (2027-2032)
4.2.3 Global Cardiotocography Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Cardiotocography Applications
5 Competition Landscape by Players
5.1 Global Cardiotocography Sales by Player (2021-2026)
5.2 Global Top Cardiotocography Players by Revenue (2021-2026)
5.3 Global Cardiotocography Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Cardiotocography revenue as of 2025
5.4 Global Cardiotocography Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Cardiotocography, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Cardiotocography, Product Type & Application
5.7 Global Key Manufacturers of Cardiotocography, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Cardiotocography Sales by Company
6.1.1.1 North America Cardiotocography Sales by Company (2021-2026)
6.1.1.2 North America Cardiotocography Revenue by Company (2021-2026)
6.1.2 North America Cardiotocography Sales Breakdown by Type (2021-2026)
6.1.3 North America Cardiotocography Sales Breakdown by Application (2021-2026)
6.1.4 North America Cardiotocography Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Cardiotocography Sales by Company
6.2.1.1 Europe Cardiotocography Sales by Company (2021-2026)
6.2.1.2 Europe Cardiotocography Revenue by Company (2021-2026)
6.2.2 Europe Cardiotocography Sales Breakdown by Type (2021-2026)
6.2.3 Europe Cardiotocography Sales Breakdown by Application (2021-2026)
6.2.4 Europe Cardiotocography Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Cardiotocography Sales by Company
6.3.1.1 China Cardiotocography Sales by Company (2021-2026)
6.3.1.2 China Cardiotocography Revenue by Company (2021-2026)
6.3.2 China Cardiotocography Sales Breakdown by Type (2021-2026)
6.3.3 China Cardiotocography Sales Breakdown by Application (2021-2026)
6.3.4 China Cardiotocography Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Cardiotocography Sales by Company
6.4.1.1 Japan Cardiotocography Sales by Company (2021-2026)
6.4.1.2 Japan Cardiotocography Revenue by Company (2021-2026)
6.4.2 Japan Cardiotocography Sales Breakdown by Type (2021-2026)
6.4.3 Japan Cardiotocography Sales Breakdown by Application (2021-2026)
6.4.4 Japan Cardiotocography Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 GE Healthcare
7.1.1 GE Healthcare Company Information
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.1.4 GE Healthcare Cardiotocography Products Offered
7.1.5 GE Healthcare Recent Development
7.2 Philips Healthcare
7.2.1 Philips Healthcare Company Information
7.2.2 Philips Healthcare Business Overview
7.2.3 Philips Healthcare Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Philips Healthcare Cardiotocography Products Offered
7.2.5 Philips Healthcare Recent Development
7.3 Edan Instruments
7.3.1 Edan Instruments Company Information
7.3.2 Edan Instruments Business Overview
7.3.3 Edan Instruments Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Edan Instruments Cardiotocography Products Offered
7.3.5 Edan Instruments Recent Development
7.4 BIOLIGHT
7.4.1 BIOLIGHT Company Information
7.4.2 BIOLIGHT Business Overview
7.4.3 BIOLIGHT Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.4.4 BIOLIGHT Cardiotocography Products Offered
7.4.5 BIOLIGHT Recent Development
7.5 ArjoHuntleigh
7.5.1 ArjoHuntleigh Company Information
7.5.2 ArjoHuntleigh Business Overview
7.5.3 ArjoHuntleigh Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.5.4 ArjoHuntleigh Cardiotocography Products Offered
7.5.5 ArjoHuntleigh Recent Development
7.6 Contec Medical Systems
7.6.1 Contec Medical Systems Company Information
7.6.2 Contec Medical Systems Business Overview
7.6.3 Contec Medical Systems Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Contec Medical Systems Cardiotocography Products Offered
7.6.5 Contec Medical Systems Recent Development
7.7 Sunray Medical Apparatus
7.7.1 Sunray Medical Apparatus Company Information
7.7.2 Sunray Medical Apparatus Business Overview
7.7.3 Sunray Medical Apparatus Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Sunray Medical Apparatus Cardiotocography Products Offered
7.7.5 Sunray Medical Apparatus Recent Development
7.8 Bionet
7.8.1 Bionet Company Information
7.8.2 Bionet Business Overview
7.8.3 Bionet Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Bionet Cardiotocography Products Offered
7.8.5 Bionet Recent Development
7.9 Luckcome
7.9.1 Luckcome Company Information
7.9.2 Luckcome Business Overview
7.9.3 Luckcome Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Luckcome Cardiotocography Products Offered
7.9.5 Luckcome Recent Development
7.10 Medgyn Products
7.10.1 Medgyn Products Company Information
7.10.2 Medgyn Products Business Overview
7.10.3 Medgyn Products Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Medgyn Products Cardiotocography Products Offered
7.10.5 Medgyn Products Recent Development
7.11 BRAEL-Medical Equipment
7.11.1 BRAEL-Medical Equipment Company Information
7.11.2 BRAEL-Medical Equipment Business Overview
7.11.3 BRAEL-Medical Equipment Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.11.4 BRAEL-Medical Equipment Cardiotocography Products Offered
7.11.5 BRAEL-Medical Equipment Recent Development
7.12 Medical ECONET
7.12.1 Medical ECONET Company Information
7.12.2 Medical ECONET Business Overview
7.12.3 Medical ECONET Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Medical ECONET Cardiotocography Products Offered
7.12.5 Medical ECONET Recent Development
7.13 BabyFun
7.13.1 BabyFun Company Information
7.13.2 BabyFun Business Overview
7.13.3 BabyFun Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.13.4 BabyFun Cardiotocography Products Offered
7.13.5 BabyFun Recent Development
7.14 Yuwell
7.14.1 Yuwell Company Information
7.14.2 Yuwell Business Overview
7.14.3 Yuwell Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Yuwell Cardiotocography Products Offered
7.14.5 Yuwell Recent Development
7.15 HealForce
7.15.1 HealForce Company Information
7.15.2 HealForce Business Overview
7.15.3 HealForce Cardiotocography Sales, Revenue and Gross Margin (2021-2026)
7.15.4 HealForce Cardiotocography Products Offered
7.15.5 HealForce Recent Development
8 Cardiotocography Manufacturing Cost Analysis
8.1 Cardiotocography Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Cardiotocography
8.4 Cardiotocography Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Cardiotocography Distributors List
9.3 Cardiotocography Customers
10 Cardiotocography Market Dynamics
10.1 Cardiotocography Industry Trends
10.2 Cardiotocography Market Drivers
10.3 Cardiotocography Market Challenges
10.4 Cardiotocography Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer